(RTTNews) - China Pharma Holdings, Inc. (CPHI) said its subsidiary Hainan Helpson Medical & Biotechnology Co. has received the Drug Supplementary Application Approval Notice for its candesartan ...

HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its ...

Objective: Intermittent activation of the renin-angiotensin system during dialysis may be related to the high risk of cardiovascular disease in dialysis patients. The aim of the present study was to ...

Review the side-effects of Candesartan as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed medical records of 50 adolescents treated at Texas Children’s Hospital Headache Clinic.

Trondheim, Norway - Results of a randomized trial suggest that the angiotensin II receptor blocker candesartan (Atacand® - AstraZeneca) may provide effective prophylaxis against migraine headaches.

The aim of this study was to test the hypothesis that losartan and candesartan have different effects on CVD-risk reduction in a real life setting with primary hypertensive treatment. The study ...

A single arm, multicenter, open-label phase II study of orally administered GW572016 as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma ...

Details concerning the Candesartan combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

Calendar: What investors need to know for the week ahead Small caps to watch: Why trading in many pot stocks were briefly halted this week. Plus, A&W, Canaccord, Interfor and more ...